Optimisation du traitement anti-hyperglycémiant chez les personnes âgées vivant avec diabète de type 2 : enjeux du surtraitement et de la déprescription
(2025) Louvain médical — Vol. 144, n° 3, p. 16-20 (2025)
Files
26-02_LMED-Mars25_5-Christiaens_revAC.pdf
prepub edit file
Open Access - Adobe PDF
- 1.77 MB
Details
- Authors
- Abstract
- (en) [Optimizing antihyperglycemic therapy in elderly people living with type 2 diabetes: challenges of overtreatment and deprescription] The treatment of type 2 diabetes in older adults presents a clinical challenge due to a benefit-risk balance that is increasingly compromised by ageing and comorbidities. This review examines the concepts of overtreatment and deprescribing of glucose-lowering treatments, which are essential for optimising the management of this heterogeneous population. Beyond highlighting their relevance, it underscores current knowledge gaps and the need for further research to develop a more individualised, effective, and safe therapeutic approach for older adults living with type 2 diabetes.
- Affiliations
Citations
Christiaens, A. (2025). Optimisation du traitement anti-hyperglycémiant chez les personnes âgées vivant avec diabète de type 2 : enjeux du surtraitement et de la déprescription. Louvain médical, 144(3), 16-20. https://hdl.handle.net/2078.5/248899 (Original work published 2025)